Eskiler, G. G. Et Al. 2019. BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY , vol.33, no.5 .

Eskiler, G. G., ÇEÇENER, G., EGELİ, Ü., & TUNCA, B., (2019). BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY , vol.33, no.5.

Eskiler, Gamze Et Al. "BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile," JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY , vol.33, no.5, 2019

Eskiler, Gamze G. Et Al. "BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile." JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY , vol.33, no.5, 2019

Eskiler, G. G. Et Al. (2019) . "BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile." JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY , vol.33, no.5.

@article{article, author={Gamze Guney Eskiler Et Al. }, title={BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile}, journal={JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY}, year=2019}